PAR 4.17% 23.0¢ paradigm biopharmaceuticals limited..

Good post Mozzarc. I haven’t read that document for a few years...

  1. 83 Posts.
    lightbulb Created with Sketch. 76
    Good post Mozzarc. I haven’t read that document for a few years but used to know it intimately. This is only one part as you have posted about the API. You then have to manufacture the vials and package, all of which needs validating and documenting in the same way. I did this for 20+ years of my working life and was involved in many FDA audits and preparing manufacturing centres for them across the world for both API and drug production. Given that iPPS has been manufactured and sold in the US for some time I do not have the data to know if an audit needs to be undertaken by FDA prior to approval for sale. I will investigate as some data is freely available on the CDC website.
    Keep up the great research and posts.
    Cheers
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.0¢
Change
-0.010(4.17%)
Mkt cap ! $80.45M
Open High Low Value Volume
24.5¢ 24.5¢ 23.0¢ $114.2K 478.8K

Buyers (Bids)

No. Vol. Price($)
9 185592 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 45500 1
View Market Depth
Last trade - 16.10pm 22/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.